Scientists originally developed them to treat type 2 diabetes, but research shows they also promote weight loss when paired with healthy habits
For patients with concerns about medication origins or ingredients, healthcare providers should offer clear, evidence-based information and address misconceptions directly
J.RensenS
Regular evaluations with your healthcare provider determine when doses can be safely reduced or when medication can be discontinued. Will insurance cover medications for binge eating disorder
Executive Summary Written by Jonathan Wright, British Clinical Pharmacist Last reviewed: February 2026 Glucagon-like peptide-1 (GLP-1) receptor agonists including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have transformed the treatment of obesity and type 2 diabetes
If reactions are severe, spreading, or persistent, a person should contact a healthcare professional